- Home
- CPIX vs NXC Comparison
CPIX vs NXC Comparison
Compare CPIX & NXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- NXC
- Stock Information
- Founded
- CPIX 1999
- NXC 1992
- Country
- CPIX United States
- NXC United States
- Employees
- CPIX N/A
- NXC N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- NXC Investment Managers
- Sector
- CPIX Health Care
- NXC Finance
- Exchange
- CPIX Nasdaq
- NXC Nasdaq
- Market Cap
- CPIX 68.7M
- NXC 79.3M
- IPO Year
- CPIX 2009
- NXC N/A
- Fundamental
- Price
- CPIX $4.70
- NXC $13.11
- Analyst Decision
- CPIX
- NXC
- Analyst Count
- CPIX 0
- NXC 0
- Target Price
- CPIX N/A
- NXC N/A
- AVG Volume (30 Days)
- CPIX 21.7K
- NXC 17.5K
- Earning Date
- CPIX 05-06-2025
- NXC 01-01-0001
- Dividend Yield
- CPIX N/A
- NXC 3.97%
- EPS Growth
- CPIX N/A
- NXC N/A
- EPS
- CPIX N/A
- NXC 0.19
- Revenue
- CPIX $41,083,299.00
- NXC N/A
- Revenue This Year
- CPIX N/A
- NXC N/A
- Revenue Next Year
- CPIX N/A
- NXC N/A
- P/E Ratio
- CPIX N/A
- NXC $70.47
- Revenue Growth
- CPIX 5.82
- NXC N/A
- 52 Week Low
- CPIX $1.04
- NXC $11.86
- 52 Week High
- CPIX $7.25
- NXC $13.70
- Technical
- Relative Strength Index (RSI)
- CPIX 52.45
- NXC 61.31
- Support Level
- CPIX $4.32
- NXC $12.89
- Resistance Level
- CPIX $4.86
- NXC $13.16
- Average True Range (ATR)
- CPIX 0.34
- NXC 0.13
- MACD
- CPIX -0.02
- NXC 0.06
- Stochastic Oscillator
- CPIX 36.89
- NXC 93.24
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About NXC Nuveen California Select Tax-Free Income Portfolio
Nuveen CA Select Tax Free Income Port is a diversified closed-end management investment company. Its objective is to provide stable dividends exempt from both regular federal and California income taxes, consistent with the preservation of capital by investing primarily in municipal obligations.